Temporal and Microspatial Heterogeneity in Transmission Dynamics of Coendemic Plasmodium vivax and Plasmodium falciparum in Two Rural Cohort Populations in the Peruvian Amazon.


Journal

The Journal of infectious diseases
ISSN: 1537-6613
Titre abrégé: J Infect Dis
Pays: United States
ID NLM: 0413675

Informations de publication

Date de publication:
23 04 2021
Historique:
received: 05 05 2020
accepted: 17 08 2020
pubmed: 22 8 2020
medline: 11 2 2022
entrez: 22 8 2020
Statut: ppublish

Résumé

Malaria is highly heterogeneous: its changing malaria microepidemiology needs to be addressed to support malaria elimination efforts at the regional level. A 3-year, population-based cohort study in 2 settings in the Peruvian Amazon (Lupuna, Cahuide) followed participants by passive and active case detection from January 2013 to December 2015. Incidence and prevalence rates were estimated using microscopy and polymerase chain reaction (PCR). Lupuna registered 1828 infections (1708 Plasmodium vivax, 120 Plasmodium falciparum; incidence was 80.7 infections/100 person-years (95% confidence interval [CI] , 77.1-84.5). Cahuide detected 1046 infections (1024 P vivax, 20 P falciparum, 2 mixed); incidence was 40.2 infections/100 person-years (95% CI, 37.9-42.7). Recurrent P vivax infections predominated onwards from 2013. According to PCR data, submicroscopic predominated over microscopic infections, especially in periods of low transmission. The integration of parasitological, entomological, and environmental observations evidenced an intense and seasonal transmission resilient to standard control measures in Lupuna and a persistent residual transmission after severe outbreaks were intensively handled in Cahuide. In 2 exemplars of complex local malaria transmission, standard control strategies failed to eliminate submicroscopic and hypnozoite reservoirs, enabling persistent transmission.

Sections du résumé

BACKGROUND
Malaria is highly heterogeneous: its changing malaria microepidemiology needs to be addressed to support malaria elimination efforts at the regional level.
METHODS
A 3-year, population-based cohort study in 2 settings in the Peruvian Amazon (Lupuna, Cahuide) followed participants by passive and active case detection from January 2013 to December 2015. Incidence and prevalence rates were estimated using microscopy and polymerase chain reaction (PCR).
RESULTS
Lupuna registered 1828 infections (1708 Plasmodium vivax, 120 Plasmodium falciparum; incidence was 80.7 infections/100 person-years (95% confidence interval [CI] , 77.1-84.5). Cahuide detected 1046 infections (1024 P vivax, 20 P falciparum, 2 mixed); incidence was 40.2 infections/100 person-years (95% CI, 37.9-42.7). Recurrent P vivax infections predominated onwards from 2013. According to PCR data, submicroscopic predominated over microscopic infections, especially in periods of low transmission. The integration of parasitological, entomological, and environmental observations evidenced an intense and seasonal transmission resilient to standard control measures in Lupuna and a persistent residual transmission after severe outbreaks were intensively handled in Cahuide.
CONCLUSIONS
In 2 exemplars of complex local malaria transmission, standard control strategies failed to eliminate submicroscopic and hypnozoite reservoirs, enabling persistent transmission.

Identifiants

pubmed: 32822474
pii: 5895494
doi: 10.1093/infdis/jiaa526
pmc: PMC8064053
doi:

Types de publication

Journal Article Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

1466-1477

Subventions

Organisme : NIAID NIH HHS
ID : U19 AI089681
Pays : United States
Organisme : NCATS NIH HHS
ID : UL1 TR001863
Pays : United States

Informations de copyright

© The Author(s) 2020. Published by Oxford University Press for the Infectious Diseases Society of America. All rights reserved. For permissions, e-mail: journals.permissions@oup.com.

Références

Lancet. 2010 Nov 6;376(9752):1592-603
pubmed: 21035841
PLoS Negl Trop Dis. 2017 Jul 3;11(7):e0005674
pubmed: 28671944
Am J Trop Med Hyg. 2015 Sep;93(3 Suppl):5-15
pubmed: 26259946
Sci Rep. 2019 Oct 23;9(1):15173
pubmed: 31645604
Int J Environ Res Public Health. 2018 Nov 27;15(12):
pubmed: 30486449
Malar J. 2015 Jul 30;14:290
pubmed: 26223450
Am J Trop Med Hyg. 2016 Dec 28;95(6 Suppl):133-144
pubmed: 27799639
Malar J. 2011 Dec 20;10:379
pubmed: 22185638
PLoS Negl Trop Dis. 2019 Nov 11;13(11):e0007876
pubmed: 31710604
PLoS One. 2010 Feb 04;5(2):e9047
pubmed: 20140220
Trends Parasitol. 2010 Mar;26(3):145-51
pubmed: 20133198
PLoS One. 2017 Oct 5;12(10):e0185742
pubmed: 28982155
Rev Peru Med Exp Salud Publica. 2011 Jun;28(2):228-36
pubmed: 21845302
Am J Trop Med Hyg. 2007 Jun;76(6):997-1008
pubmed: 17556601
Malar J. 2013 Aug 30;12:303
pubmed: 24001096
Malar J. 2017 Aug 4;16(1):312
pubmed: 28778210
Lancet. 2020 Apr 25;395(10233):e67
pubmed: 32334704
J Clin Microbiol. 2005 May;43(5):2435-40
pubmed: 15872277
Parasit Vectors. 2015 May 07;8:261
pubmed: 25948081
J Clin Epidemiol. 2019 Sep;113:137-146
pubmed: 31146022
Malar J. 2018 Feb 20;17(1):86
pubmed: 29463241
Malar J. 2017 Oct 16;16(1):415
pubmed: 29037202
Am J Trop Med Hyg. 2016 Dec 28;95(6 Suppl):62-71
pubmed: 27430544
JCI Insight. 2020 Jan 16;5(1):
pubmed: 31770108
N Engl J Med. 2019 Jan 17;380(3):229-241
pubmed: 30650326
Am J Trop Med Hyg. 2015 Sep;93(3 Suppl):1-4
pubmed: 26574613
N Engl J Med. 2019 Jan 17;380(3):215-228
pubmed: 30650322
PLoS One. 2015 Sep 10;10(9):e0137458
pubmed: 26356311
Malar J. 2016 May 10;15(1):266
pubmed: 27165432
Am J Trop Med Hyg. 2008 Oct;79(4):624-35
pubmed: 18840755
Malar J. 2005 Jun 23;4:27
pubmed: 15975146
Am J Trop Med Hyg. 2000 Feb;62(2):247-56
pubmed: 10813480
Acta Trop. 2012 Mar;121(3):281-91
pubmed: 22015425
Sci Rep. 2017 Jan 16;7:40350
pubmed: 28091560
PLoS Negl Trop Dis. 2016 Jan 14;10(1):e0004376
pubmed: 26766548
Adv Parasitol. 2013;81:77-131
pubmed: 23384622
Parasitology. 2016 Feb;143(2):154-70
pubmed: 26864134

Auteurs

Angel Rosas-Aguirre (A)

Research Institute of Health and Society, Université Catholique de Louvain, Brussels, Belgium.
Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú.

Mitchel Guzman-Guzman (M)

Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú.
Laboratorio International Centers of Excellence in Malaria Research-Amazonia, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú.

Raul Chuquiyauri (R)

Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú.
Laboratorio International Centers of Excellence in Malaria Research-Amazonia, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú.

Marta Moreno (M)

Division of Infectious Diseases, Department of Medicine, University of California San Diego, La Jolla, California, USA.
London School of Hygiene and Tropical Medicine, Department of Immunology and Infection, London, United Kingdom.

Paulo Manrique (P)

Laboratorio International Centers of Excellence in Malaria Research-Amazonia, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú.

Roberson Ramirez (R)

Laboratorio International Centers of Excellence in Malaria Research-Amazonia, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú.

Gabriel Carrasco-Escobar (G)

Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú.
Laboratorio International Centers of Excellence in Malaria Research-Amazonia, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú.
Division of Infectious Diseases, Department of Medicine, University of California San Diego, La Jolla, California, USA.

Hugo Rodriguez (H)

Dirección Regional de Salud Loreto DIRESA Loreto, Loreto, Perú.

Niko Speybroeck (N)

Research Institute of Health and Society, Université Catholique de Louvain, Brussels, Belgium.

Jan E Conn (JE)

Wadsworth Center, New York State Department of Health, Albany, New York, USA.
Department of Biomedical Sciences, School of Public Health, University at Albany, State University of New York, Albany, New York, USA.

Dionicia Gamboa (D)

Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú.
Laboratorio International Centers of Excellence in Malaria Research-Amazonia, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú.
Departamento de Ciencias Celulares y Moleculares, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú.

Joseph M Vinetz (JM)

Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú.
Laboratorio International Centers of Excellence in Malaria Research-Amazonia, Laboratorios de Investigación y Desarrollo, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú.
Departamento de Ciencias Celulares y Moleculares, Facultad de Ciencias y Filosofía, Universidad Peruana Cayetano Heredia, Lima, Perú.
Section of Infectious Diseases, Department of Internal Medicine, Yale School of Medicine, New Haven, Connecticut, USA.

Alejandro Llanos-Cuentas (A)

Instituto de Medicina Tropical Alexander von Humboldt, Universidad Peruana Cayetano Heredia, Lima, Perú.
Facultad de Salud Pública y Administración, Universidad Peruana Cayetano Heredia, Lima, Perú.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH